A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
Clinical trial NCT04773951 · COMPLETED
Trial details
- NCT number
- NCT04773951
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2023-04-18
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.